Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 1 hour ago
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation...
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 7, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin...
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 27, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation...
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Silapo, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 18, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Silapo, epoetin zeta, Date of...
Human medicines European public assessment report (EPAR): Elmiron, pentosan polysulfate sodium, Date of authorisation: 02/06/2017, Revision: 15, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Elmiron, pentosan polysulfate sodium, Date...
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation: 25/06/2018, Revision: 9, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation...
Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 11, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine...
Orphan designation: tobevibart Treatment of hepatitis delta virus infection, 13/12/2024 Positive
about 22 hours ago
Orphan designation: tobevibart Treatment of hepatitis delta virus infection, 13/12/2024 Positive